Retinopathy
24
5
6
10
Key Insights
Highlights
Success Rate
77% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
12.5%
3 terminated out of 24 trials
76.9%
-9.6% vs benchmark
8%
2 trials in Phase 3/4
0%
0 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (24)
MIRACLE-T2D Montelukast Intervention for Renal, Cardiovascular and Eye Health in Type 2 Diabetes
Stem Cell Ophthalmology Treatment Study II
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
Study of Stimulus Parameters in Flicker Electroretinogram (ERG)
Early Genetic Identification of Obesity
Study of the Involvement of Fatty Acids in Retinopathy of Prematurity: Relationship Between Retinopathy of Prematurity and the Rate of Expression of Transplacental Fatty Acid Receptors.
Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines
Multisensory Stimulation Versus White Noise
Cognitive Impairment, Retinopathy, and Cerebrovascular Lesions in the Elderly
Telemedicine Retinal Screening Utilizing a Mobile Medical Unit
Time To Complications Occurs in Diabetes
Feasibility of an Intervention to Increase Diabetic Retinopathy Screening Attendance
Corneal Confocal Microscopy to Detect Diabetic Neuropathy in Children
EPI-743 in Cobalamin C Defect: Effects on Visual and Neurological Impairment
Identification of New Genes Implicated in Rare Neurosensory Diseases by Whole Exome Sequencing
Registration and Treatment of Pain During Eye Examination of Prematurity
Characteristic Analysis of Retinopathy Associated With High Doses of Interferon α-2b Therapy
Anesthesia for Retinopathy of Prematurity
Ranibizumab for Neovascularization in Sickle Cell Retinopathy